- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07555912
Intervention of Mindfulness Training on Attention Network and Negative Emotion Regulation in Adolescent Badminton Players
A Randomized Controlled Trial of an 8-Week Mindfulness-Based Training Intervention on Attentional Networks and Emotional Regulation Among 12-to-18-Year-Old Municipal-Level Badminton Athletes
Study Overview
Status
Intervention / Treatment
Detailed Description
Background: Adolescent competitive badminton athletes often face high levels of competitive stress and attentional demands, which can negatively affect emotional regulation and performance. Mindfulness training has shown promise in improving attention and emotional control in athletes, but its specific effects on municipal-level adolescent badminton players remain understudied.
Objective: To evaluate the effects of an 8-week mindfulness-based training intervention on attentional network efficiency and emotion regulation capacities in 12-18-year-old municipal-level badminton athletes.
Methods: This is a single-center, two-arm randomized controlled trial. Eligible athletes are randomly allocated to either the intervention group or the control group. The intervention group receives an 8-week mindfulness training program consisting of twice-weekly guided sessions (90 minutes each), plus optional daily home practice. The control group continues with their standard badminton training routine without additional mindfulness training. Outcome measures include attentional network tests and emotion regulation scales, assessed at baseline and post-intervention.
Expected Outcomes: It is hypothesized that the mindfulness training group will show significant improvements in attentional alerting, orienting, and executive control, as well as better emotional regulation compared to the control group. The findings may provide practical evidence for incorporating mindfulness training into youth athlete development programs.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510500
- Guangzhou Sport University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion CInclusion Criteria:
Aged 12-18 years old Registered municipal-level badminton athletes No prior systematic mindfulness training experience Able to complete all assessments and training sessions
Exclusion Criteria:
History of severe mental disorders or neurological diseases Taking any psychotropic medication Major injury or surgery within the past 3 months Participation in other psychological intervention programs during the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Training Group
Participants receive 8 weeks of mindfulness training (twice weekly 90-minute guided sessions, plus optional daily home practice) in addition to their regular badminton training.
|
8-week mindfulness-based training program consisting of twice-weekly 90-minute guided sessions, including mindfulness meditation, body scan, and mindful movement, plus optional daily home practice.
|
|
No Intervention: Control Group
Participants continue with their regular badminton training routine only, without additional mindfulness training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Attentional Network Efficiency
Time Frame: Baseline, immediately after 8-week intervention
|
Change in attentional network function (alerting, orienting, and executive control) measured by the Attentional Network Test (ANT), from baseline to post-intervention (8 weeks).
|
Baseline, immediately after 8-week intervention
|
|
Change in Emotion Regulation Capacity
Time Frame: Baseline, immediately after 8-week intervention
|
Change in emotion regulation ability measured by the Emotion Regulation Questionnaire (ERQ), from baseline to post-intervention (8 weeks).
|
Baseline, immediately after 8-week intervention
|
|
Change in Prefrontal Cortex Oxygenated Hemoglobin (HbO) Concentration
Time Frame: Baseline, immediately after 8-week intervention
|
Change in prefrontal cortex oxygenated hemoglobin (HbO) concentration during resting state and cognitive tasks, measured by functional near-infrared spectroscopy (fNIRS), from baseline to post-intervention (8 weeks).
|
Baseline, immediately after 8-week intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Skin Conductance Level (SCL)
Time Frame: Baseline, immediately after 8-week intervention
|
Change in resting-state and task-evoked skin conductance level (SCL), measured by electrodermal activity (EDA) recording, from baseline to post-intervention (8 weeks).
|
Baseline, immediately after 8-week intervention
|
|
Change in Resting Heart Rate (HR)
Time Frame: Baseline, immediately after 8-week intervention
|
Change in resting heart rate (HR) during baseline and post-intervention assessment sessions.
|
Baseline, immediately after 8-week intervention
|
|
Change in Resting Respiratory Rate (RR)
Time Frame: Baseline, immediately after 8-week intervention
|
Change in resting respiratory rate (RR) during baseline and post-intervention assessment sessions.
|
Baseline, immediately after 8-week intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024LCLL-30
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mindfulness Training
-
University of California, San DiegoCompleted
-
Yale UniversityCompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) | Mental Health Wellness 1 | War-Related TraumaJordan
-
King's College LondonCompletedAdults With Overweight and ObesityUnited Kingdom
-
University of HoustonCompletedDepression | Stress | Anxiety | Well-beingUnited States
-
Boston University Charles River CampusTerminatedSmoking CessationUnited States
-
Freie Universität BerlinCharite University, Berlin, GermanyCompletedMajor Depressive Disorder
-
The Miriam HospitalCompleted
-
Bayburt UniversityNot yet recruitingFear of Childbirth | Mindfulness | Self-Efficacy | Attachment | Haptonomy
-
Universidad de AntioquiaCompletedHealthy VolunteersColombia